HyperFlex Medical

HyperFlex Medical is a medical technology company addressing the underserved market of mild-to-moderate bunion correction. The company was founded by Dr. Joe Geldwert, an accomplished foot and ankle surgeon, who also serves as Chief Clinical Officer and invented the company's core product. The leadership team is bolstered by CEO Bob Peterhans, former President of Zimmer Trauma, and CTO Brian Schumacher, former VP of R&D at Engage Surgical. HyperFlex Medical operates in the orthopedic and podiatric markets, targeting surgeons as its primary clients. Its business model centers on selling its proprietary bunion correction system and associated disposable instrumentation, scaling through specialty distributors. The company's revenue is generated from the average selling price (ASP) of its system, with reimbursement available to providers under existing CPT codes.

The company's flagship product, the HyperFlex® Bunion Correction System, is a minimally invasive solution for hallux valgus deformities. It received FDA 510(k) clearance and is protected by a robust intellectual property portfolio, including three U.S. and three EU patents. The system is designed to correct the intermetatarsal angle by gently realigning and stabilizing the first and second metatarsal bones with a small, flexible implant and a suture, avoiding the need for bone cutting (osteotomy) or fusion. This bone-preserving technique is a key differentiator from traditional, more invasive surgeries. The procedure is completed in approximately 20-30 minutes through a single small incision and allows for immediate weight-bearing post-operation, significantly speeding up recovery. Mechanical testing has shown the implant to be 12 times stronger than clinical load requirements, supporting its durability. This approach is intended to reduce complication rates, such as second metatarsal fractures, which can occur with other surgical methods. By focusing on early-stage intervention for the 93% of bunion sufferers who are often told to wait for their condition to worsen, HyperFlex Medical aims to expand the addressable market significantly. In June 2025, the company secured a $1.4 million investment from Easton Capital to accelerate commercial rollout and team expansion.

Keywords: bunion correction, hallux valgus, minimally invasive surgery, orthopedic implant, podiatry, foot and ankle surgery, non-osteotomy, medical device, Joe Geldwert, Bob Peterhans, bone-preserving, surgical instrumentation, medtech, orthopedic market, immediate weight bearing, fast recovery surgery, FDA 510(k) clearance, surgical efficiency, ambulatory surgery, bunion treatment